High-Throughput Nucleotide Sequencing
"High-Throughput Nucleotide Sequencing" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Techniques of nucleotide sequence analysis that increase the range, complexity, sensitivity, and accuracy of results by greatly increasing the scale of operations and thus the number of nucleotides, and the number of copies of each nucleotide sequenced. The sequencing may be done by analysis of the synthesis or ligation products, hybridization to preexisting sequences, etc.
| Descriptor ID |
D059014
|
| MeSH Number(s) |
E05.393.760.319
|
| Concept/Terms |
High-Throughput Nucleotide Sequencing- High-Throughput Nucleotide Sequencing
- High Throughput Nucleotide Sequencing
- Nucleotide Sequencing, High-Throughput
- Sequencing, High-Throughput Nucleotide
Massively-Parallel Sequencing- Massively-Parallel Sequencing
- Massively Parallel Sequencing
- Sequencing, Massively-Parallel
- Sequencings, Massively-Parallel
High-Throughput RNA Sequencing- High-Throughput RNA Sequencing
- High Throughput RNA Sequencing
- RNA Sequencing, High-Throughput
- Sequencing, High-Throughput RNA
Deep Sequencing- Deep Sequencing
- Deep Sequencings
- Sequencing, Deep
- Sequencings, Deep
High-Throughput DNA Sequencing- High-Throughput DNA Sequencing
- DNA Sequencing, High-Throughput
- High Throughput DNA Sequencing
- High-Throughput DNA Sequencings
- Sequencing, High-Throughput DNA
|
Below are MeSH descriptors whose meaning is more general than "High-Throughput Nucleotide Sequencing".
Below are MeSH descriptors whose meaning is more specific than "High-Throughput Nucleotide Sequencing".
This graph shows the total number of publications written about "High-Throughput Nucleotide Sequencing" by people in this website by year, and whether "High-Throughput Nucleotide Sequencing" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 1 | 1 | 2 |
| 2011 | 3 | 6 | 9 |
| 2012 | 11 | 12 | 23 |
| 2013 | 11 | 14 | 25 |
| 2014 | 15 | 21 | 36 |
| 2015 | 14 | 41 | 55 |
| 2016 | 24 | 50 | 74 |
| 2017 | 18 | 25 | 43 |
| 2018 | 12 | 40 | 52 |
| 2019 | 10 | 19 | 29 |
| 2020 | 9 | 29 | 38 |
| 2021 | 14 | 21 | 35 |
| 2022 | 6 | 20 | 26 |
| 2023 | 1 | 15 | 16 |
| 2024 | 11 | 22 | 33 |
| 2025 | 3 | 4 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "High-Throughput Nucleotide Sequencing" by people in Profiles.
-
Identification of genetic determinants of antibiotic resistance in Helicobacter pylori isolates in Vietnam by high-throughput sequencing. BMC Microbiol. 2025 May 02; 25(1):264.
-
Identification of Hepatic-like EPO as a Cause of Polycythemia. N Engl J Med. 2025 May 01; 392(17):1684-1697.
-
Closing the gaps, and improving somatic structural variant analysis and benchmarking using CHM13-T2T. Genome Res. 2025 Apr 14; 35(4):621-631.
-
Unraveling the hidden complexity of cancer through long-read sequencing. Genome Res. 2025 Apr 14; 35(4):599-620.
-
A Hitchhiker's Guide to long-read genomic analysis. Genome Res. 2025 Apr 14; 35(4):545-558.
-
K-mer analysis of long-read alignment pileups for structural variant genotyping. Nat Commun. 2025 Apr 04; 16(1):3218.
-
Comprehensive biomarker profiles in hematological malignancies: improving diagnosis, prognosis, and treatment. Biomark Med. 2025 Mar; 19(6):223-238.
-
Comparing the clinical utility of pharmacogenomic genotyping and next generation sequencing in a military health system adult medicine clinic. Pharmacogenomics. 2024; 25(16-18):637-645.
-
Next-Generation Sequencing-Based MSI Scoring Predicts Benefit in Mismatch Repair-Deficient Tumors Treated with Nivolumab: Follow-up on NCI-MATCH Arm Z1D. Clin Cancer Res. 2025 Feb 17; 31(4):667-677.
-
A rapid turnaround time workflow for a cytological liquid biopsy assay using FNA supernatant specimens. Cancer Cytopathol. 2025 01; 133(1):e22925.